BRUSSELS, BELGIUM / RankWire.AI / – The European Commission has broadened its Ebola containment efforts by securing €2.1 million to purchase PCR tests for the Bundibugyo virus outbreak. This agreement covers open-platform testing kits that laboratories can utilize with their existing equipment, with the procurement process backed by the European Health and Digital Executive Agency. Dispatches are scheduled to begin in August, as health teams face a significant outbreak centered in the Democratic Republic of the Congo and extending to neighboring regions.
The World Health Organization will facilitate the distribution of these tests through its Hub for Global Health Emergencies Logistics based in Dubai. WHO will coordinate the allocation of supplies to various locations involved in the Ebola response. PCR testing plays a crucial role by enabling laboratories to confirm infections swiftly and support ongoing surveillance around active cases. Confirmed results guide patient treatment, isolation procedures, and contact tracing efforts. The latest batch of supplies enhances laboratory capacity at a critical time when authorities continue monitoring the transmission across multiple provinces and health zones within the Democratic Republic of the Congo.
Earlier, the European Commission allocated another €2.5 million for rapid molecular point-of-care tests and testing instruments aimed at supporting the regional response led by the Africa Centres for Disease Control and Prevention. The combined value of these two diagnostic agreements now reaches €4.6 million. This funding forms part of a wider European assistance package, which includes medical supplies, preparedness initiatives, and public health resources intended to strengthen responses in affected and neighboring areas confronting the Bundibugyo Ebola crisis.
Testing capabilities expand amid a major outbreak
By August 12, WHO figures indicated that the Democratic Republic of the Congo had reported 4,665 confirmed cases and 2,184 deaths, with infections identified across 54 health zones in six provinces, namely Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized this as the largest Ebola epidemic recorded within the country, emphasizing ongoing transmission across interconnected geographic clusters that continually challenge surveillance teams, laboratories, treatment centers, and local health services.
In its August update, WHO maintained a very high national risk level for the Democratic Republic of the Congo, while assigning a high risk to neighboring countries and a low risk elsewhere. Following a meeting of its International Health Regulations Emergency Committee on August 24, WHO issued updated temporary recommendations focusing on surveillance, case detection, infection prevention, clinical management, and community involvement. The guidelines also address public health measures concerning mobility and large gatherings amid the persistent response efforts.
European health support exceeds €493 million
The European Commission announced the mobilization of €493 million for emergency relief, vaccination campaigns, treatment initiatives, and health security across the Great Lakes and Uganda regions. European health agencies have also contributed to laboratory diagnostics, disease surveillance, and preparedness activities. According to the European Centre for Disease Prevention and Control, the risk to populations in Europe remains very low; since Ebola predominantly spreads through direct contact with infected bodily fluids, rapid detection, safe clinical practices, and strict infection control remain essential to limiting further transmission.
The Bundibugyo virus outbreak continues to be classified as a public health emergency of international concern under WHO’s international health regulations. Currently, there are no approved vaccines or specific treatments targeting Bundibugyo virus disease, so authorities rely heavily on surveillance, rapid diagnosis, isolation, clinical management, infection prevention, and close contact monitoring. The new PCR testing supplies bolster these efforts, as WHO, Africa CDC, and national health authorities coordinate their responses to identify cases promptly and sustain public health measures within affected communities.